 |
|
|
|||||
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business pressures. However, operations in India, Europe, and emerging markets show healthy growth. New launches like Semaglutide and Abatacept are expected to drive future expansion. Margins are set to improve with better product mix and cost controls.
Category:
News and Media
Investor interest in unlisted shares is decreasing. Trading volumes have fallen significantly. This slowdown is due to lower prices and fewer new share offerings. Some popular companies still see activity. However, demand has softened in sectors like defence and hospitality. A stronger stock market is expected to boost this segment again.
Category:
News and Media
Three out of twelve economists anticipate the Reserve Bank of India will raise policy rates this fiscal year due to inflation concerns, while others predict a prolonged pause. Most economists expect inflation to exceed RBI's forecast for FY27, with the bond market already pricing in tighter monetary policy.
Category:
News and Media
US stocks advanced with the S&P 500 and Nasdaq hitting record closing highs as AI-linked tech and chip stocks powered gains despite hotter inflation data. Producer prices surged, reinforcing expectations of prolonged Fed tightening. Markets also tracked Trump-Xi talks and rising geopolitical risks, while Morgan Stanley lifted its S&P target.
Category:
News and Media
Shares of Steel Authority of India (SAIL) jumped 14% on Wednesday, driven largely by a short squeeze as traders with heavy bearish derivative positions were forced to cover shorts. Extremely high MWPL utilisation and concentrated bets among a few clients amplified the rally as stop-loss triggers accelerated buying pressure.
Category:
News and Media
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »